Partner at SOSV & Managing Director at Indiebio
Stephen heads the IndieBio NY program, has a Ph.D. in Molecular Biology, and has a deep background in entrepreneurship in the bio/pharma industry. Stephen was one of the founding scientists at Vertex Pharmaceuticals, working on many drug discovery programs, resulting in the FDA approval of Agenerase & Lexiva. He went on to co-found Abpro Therapeutics, employing synthetic biology and immunology to accelerate antibody discovery and development. Recruited as CEO of the Innovation and Knowledge Center for Synthetic Biology in the UK, he oversaw a dramatic growth in the synthetic biology innovation ecosystem with a record number of startups and fundraising in this sector. At the same time, Stephen co-founded Bio-start, the UK’s first Life Science accelerator. Stephen has co-authored over 30 peer-reviewed scientific publications, including publications appearing in Nature and Cell, and has several issued patents. He has been featured in Huffington Post, Upstart, BioScience, and is a regular conference speaker and government advisor on Life Science innovation and entrepreneurship. Recently awarded Royal Society Entrepreneur in Residence at Imperial College London, Stephen is a Member of the Royal Society’s Industrial Fellows College and Fellow of the Royal Society of Biology.